$28.760
+0.446 (+1.55%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KMTS Prediction & Forecast by Similar Chart Analysis
Alphio's KMTS stock price prediction model matches the current Kestra Medical Technologies Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $28.56 (-0.68%). The 1-week path is $28.43 (-1.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kestra Medical Technologies Ltd Stock?
Kestra Medical Technologies is a good buy right now due to its strong revenue growth of 60% year-over-year, reaching $30.97 million in Q1 2027, and a gross margin improvement to 56.5%, which is up over 10 percentage points year-over-year. Despite a net loss of $44.09 million, the company's positive outlook and raised revenue guidance for 2027 to $141 million indicate strong market potential. The main risk is the significant net loss per share of $0.75, which reflects ongoing operational challenges.
KMTS stock price ended at $28.76 on Friday, after rising +1.55%
Kestra Medical Technologies Ltd (KMTS) last closed at $28.76, gaining +1.55%. These facts feed the 1-day and 1-week KMTS price prediction above.
Forecast Drivers
Kestra Medical Technologies Ltd (KMTS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches KMTS, ranked by similarity.
Seasonality analysis for KMTS
Historically the probability of a positive October return for KMTS is 100.00%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.